基因型鑒定市場規模、佔有率及成長分析（依產品、技術、應用、最終用途及地區）－2025-2032 年產業預測

2023 年基因型鑒定市場規模價值 163 億美元，預計將從 2024 年的 182.9 億美元成長到 2032 年的 459.3 億美元，預測期內（2025-2032 年）的複合年成長率為 12.2%。

受基因組學、個人化醫療創新以及基因檢測服務需求不斷成長的推動，全球基因型鑒定市場正在經歷顯著成長。這種擴張主要是由於遺傳疾病盛行率的上升、公眾對早期疾病檢測意識的提高以及精準醫療的進步。微陣列、聚合酵素鏈鎖反應(PCR) 和次世代定序(NGS) 等廣泛使用的技術對於研究和臨床應用都至關重要。此外，基因型鑒定資料與生物資訊學和分析工具的整合進一步推動了市場的成長。在競爭日益激烈的環境中，產業領導者優先考慮產品創新、擴大其基因檢測服務範圍並建立策略聯盟，以提升其在快速成長的全球市場中的地位。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析

基因型鑒定市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 裝置
• 試劑和套件
• 軟體和服務

基因型鑒定市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• PCR
• 毛細管電泳
• 微陣列
• 定序
• 質譜法
• 其他

基因型鑒定市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 藥物基因組學
• 診斷及個人化醫療
• 農業生物技術
• 動物遺傳學
• 其他

基因型鑒定市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 製藥和生物製藥公司
• 診斷與研究實驗室
• 學術機構
• 其他

基因型鑒定市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（United States）
• Illumina, Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Danaher Corporation（United States）
• PerkinElmer, Inc.（United States）
• Fluidigm Corporation（United States）
• Eurofins Scientific（Luxembourg）
• Pacific Biosciences of California, Inc.（United States）
• Oxford Nanopore Technologies Ltd.（United Kingdom）
• Takara Bio Inc.（Japan）

結論和建議

Genotyping Market size was valued at USD 16.3 billion in 2023 and is poised to grow from USD 18.29 billion in 2024 to USD 45.93 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global genotyping market is witnessing significant growth propelled by innovations in genomics, personalized medicine, and heightened demand for genetic testing services. This expansion is primarily driven by the rising incidence of genetic disorders, increasing public awareness regarding early disease detection, and advancements in precision medicine. Widely utilized technologies such as microarrays, polymerase chain reaction (PCR), and next-generation sequencing (NGS) are essential for both research and clinical applications. Furthermore, the integration of genotyping data with bioinformatics and analytics tools is further catalyzing market growth. As competition intensifies, leading industry players are prioritizing product innovation, broadening their genetic testing offerings, and forming strategic alliances to enhance their market position in the burgeoning global genotyping landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genotyping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genotyping Market Segments Analysis

Global Genotyping Market is segmented by Product, Technology, Application, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Software and Services. Based on Technology, the market is segmented into PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry and Others. Based on Application, the market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others. Based on End-use, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genotyping Market

A significant factor propelling the global genotyping market is the heightened occurrence of genetic disorders alongside the escalating need for personalized medicine. Genotyping is essential in detecting genetic variations, mutations, and specific gene sequences linked to particular diseases and responses to medications. Recent advancements in genomic research and improved insights into genetic markers empower tailored diagnosis, treatment options, and drug selection. As the incidence of genetic disorders rises and there is a progressive shift towards precision medicine, the demand for innovative genotyping technologies and services continues to grow, further driving the market's expansion and relevance.

Restraints in the Genotyping Market

A major limitation in the global genotyping market pertains to the ethical and privacy issues surrounding genetic testing. The ability to access personal genetic data brings forth worries regarding potential misuse or misinterpretation of this sensitive information. Issues related to informed consent, data protection, and the risk of discrimination based on genetic insights create obstacles to the broader acceptance of genotyping. Furthermore, the proper interpretation and communication of genetic test results to both individuals and healthcare providers necessitate thoughtful approaches to ensure accurate understanding and appropriate follow-up actions. Effectively addressing these ethical and privacy challenges is essential for fostering trust, encouraging participation, and ensuring the responsible application of genotyping technologies.

Market Trends of the Genotyping Market

The global genotyping market is witnessing a significant trend towards personalized medicine and precision healthcare, fueled by an increasing demand for customized treatment solutions. As advancements in genomic technologies and the plummeting costs of genotyping enhance accessibility for healthcare providers and researchers, the capability to uncover genetic variations linked to diseases and drug responses becomes paramount. This enables the development of tailored treatment plans that optimize patient outcomes through targeted therapies and improved disease management. The growing awareness of the genetic underpinnings of various conditions is accelerating this trend, positioning genotyping as a cornerstone of modern healthcare innovations aimed at individualized patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Genotyping Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits
• Software and Services

Global Genotyping Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR
• Capillary Electrophoresis
• Microarrays
• Sequencing
• Mass Spectrometry
• Others

Global Genotyping Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmacogenomics
• Diagnostics and Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others

Global Genotyping Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biopharmaceutical Companies
• Diagnostics and Research Laboratories
• Academic Institutes
• Others

Global Genotyping Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations